Back to Journals » Therapeutics and Clinical Risk Management » Volume 18

Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]

Authors Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H

Received 8 August 2022

Accepted for publication 8 August 2022

Published 10 August 2022 Volume 2022:18 Pages 785—786


Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H. Ther Clin Risk Manag. 2010;6:593–600.

The Editor and Publisher of Therapeutics and Clinical Risk Management wish to retract the published article. Following publication of the Expression of Concern, this article has been retracted due to acknowledgement of allegations of scientific misconduct regarding data integrity, inappropriate authorship, duplicate reporting, ethical oversight, and data fabrication. In addition, it has been recognised that numerous other publications from this research group have also been retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.